Home › Funds › Eversept Partners, LP › ABVX
Eversept Partners, LP position in ABVX
ABIVAX SA · Health Care
Eversept Partners, LP reported holding 913,880 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$121.8M, representing 6.37% of its reported portfolio and ranking #2 among its reported holdings. Eversept Partners, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's ABVX position evolved
Eversept Partners, LP first disclosed a stake in ABVX in Q3 2025 at 426,499 shares (US$36.2M). The position peaked in Q2 2026 at 913,880 shares, worth US$121.8M. Across 4 filings, Eversept Partners, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 913,880 shares valued at US$121.8M — a reduction of -20,543 shares quarter over quarter.. Notable position changes include a 54% increase in Q4 2025 (shares fell 17% over the following quarter), a 42% increase in Q1 2026 (shares rose 20% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 426.50K | $36.21M | New |
| Q4 2025 | 657.83K | $88.71M | Add |
| Q1 2026 | 934.42K | $104.05M | Add |
| Q2 2026 | 913.88K | $121.78M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Helikon Investments Ltd 2.79M sh · $371.41M · Q2 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.31M sh · $174.55M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Logos Global Management LP 1.02M sh · $136.46M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 765.33K sh · $101.99M · Q2 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
- Boxer Capital Management, LLC 605.00K sh · $80.62M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held ABVX?
Eversept Partners, LP has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Eversept Partners, LP's current position in ABVX?
As of Q2 2026, Eversept Partners, LP holds 913.88K shares of ABVX (ABIVAX SA), valued at $121.78M, representing 6.37% of its reported portfolio and ranking #2.
Has Eversept Partners, LP been buying or selling ABVX?
In the latest 13F filing (Q2 2026), Eversept Partners, LP reduced its position in ABVX. The position peaked in Q2 2026 at 913.88K shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.